The U.S. Food and Drug Administration on ‌Thursday approved Johnson & Johnson's treatment for a type of blood cancer, making ...

March 4 (Reuters) - Johnson & Johnson has launched a website to sell some of its drugs directly to U.S. patients who either ...

On Thursday, the U.S. Food and Drug Administration approved Johnson & Johnson‘s JNJ Tecvayli in combination with Darzalex Faspro for patients with relapsed or refractory multiple myeloma. The agency ...

Bayer sued Johnson and Johnson, alleging false advertising for its prostate cancer drug Erleada, claiming it misleads patients.

A Baltimore jury ordered Johnson & Johnson and its subsidiaries to pay over $1.5 billion to a woman who claimed decades of exposure to asbestos in the company’s talc-based products caused her ...

Johnson & Johnson has won U.S. Food and Drug Administration fast-track designation for its investigational nipocalimab drug in adults with systemic lupus erythematosus, a chronic autoimmune disease.

A Los Angeles jury awarded $40 million on Friday to two women who claimed that talcum powder made by Johnson & Johnson caused their ovarian cancer. The giant health care company said it would appeal ...

Jessica Dean, of Dallas-based Dean Omar Branham Shirley, talked to Law.com about the $1.5 billion talc verdict that jurors in Baltimore, Maryland, returned on Monday against Johnson & Johnson. The ...

Johnson & Johnson has teamed up with Naomi Watts to put a clearer focus on vision health, leveraging the actor’s star power to encourage women over 40 to make eye exams part of their self-care ...

TD Cowen 46th Annual Health Care Conference March 3, 2026 11:10 AM ESTCompany ParticipantsJoseph Wolk - Executive VP ...

AUSTIN, Texas — Texas Attorney General Ken Paxton said he scored what he calls a "major win" against pharmaceutical giant Johnson & Johnson and its spinoff, consumer health company Kenvue. The ...

Johnson & Johnson could become the second biopharma company to achieve $100 billion in annual sales. The healthcare leader has a robust and diversified business that can support its dividend program.